secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001193125-22-292625
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises $3.8M via private placement of 7.14M shares at $0.5293 per share
--------------------------------------------------------------------------------

- Issued 7,142,496 shares to accredited investors for gross proceeds of ~$3.8 million.
- Insider participation: CEO Maurice Zauderer, chairman Albert Friedberg, directors Jacob Frieberg and Gerald Van Strydonck.
- Proceeds to fund pepinemab clinical trials and for working capital.
- Registration rights agreement filed to register shares for resale within 75 days after closing.
- Shares sold under Section 4(a)(2) and Rule 506 of Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522292625/0001193125-22-292625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522292625/d391207d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-292625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer